S

Shenzhen Salubris Pharmaceuticals Co.,LTD

436 employees

Shenzhen Salubris Pharmaceuticals is a comprehensive pharmaceutical company.

Investor insights

Sectors invested in

Pharmaceutical5

Health Care5

Biotechnology5

Medical2

Antibody-Drug Conjugates2

Cardiovascular2

Antibody Engineering2

Oncology2

Bi-Specific Antibodies2

Electrophysiology Recording System1

Cellular engineering1

Glycoproteomics1

Drug development1

Antobody developement1

O-glycosylation1

Glycopeptides1

Antigen development1

Therapeutics1

Biopharma1

Manufacturing1

Funding rounds participated in

$14M sweet spot round size

Most of their 8 investments are in rounds between $10M and $20M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology

Pharmaceutical

RX for Cardiovascular

Health Care

Bio-pharmaceutical

antibiotics

Interventional medical device

Date founded

1998

Investments made

普

普瑞基准科技(北京)有限公司 raised $14M on June 26, 2023

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

S

Salubris Biotherapeutics raised $35M on March 28, 2023

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

S

Salubris Biotherapeutics raised $32M on March 7, 2022

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

M

Mercator MedSystems, Inc. raised $14M on June 13, 2019

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

V

Viracta Therapeutics, Inc. raised $10M on December 4, 2018

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

U

Undisclosed raised $20M on January 22, 2018

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

S

Sichuan Jinjiang Electronic Science and Technology Co., Ltd. raised undisclosed on January 16, 2018

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

G

GO Therapeutics raised $5M on August 17, 2017

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

FAQ